Here, we studied whether TPC2 may play different roles in melanoma in terms of primary and metastatic tumours, and also demonstrate for the first time a connection between TPC2, Ca2+ signalling, and the activation of the HIPPO signalling pathway. This evidence concerns the gene TPCN2 and metastatic neoplasm.